Hans Berger Department of Neurology, Jena University Hospital, Erlanger Allee 101, Jena, Germany.
Mov Disord. 2012 Jul;27(8):1019-25. doi: 10.1002/mds.25087. Epub 2012 Jun 21.
A number of neuropathological studies have demonstrated that the olfactory system is among the first brain regions affected in Parkinson's disease (PD). These findings correlate with pathophysiological and pathological data that show a loss in olfactory bulb (OB) volume in patients with PD. However, to date, MRI has not been a reliable method for the in vivo detection of this volumetric loss in PD. Using a 3.0-Tesla MRI constructive interference in the steady-state sequence, OB volume was evaluated in patients with PD (n = 16) and healthy control subjects (n = 16). A significant loss of OB volume was observed in patients with PD, compared to the healthy control group (91.2 ± 15.72 versus 131.4 ± 24.56 mm(3) , respectively). Specifically, decreased height of the left OB appears to be a reliable parameter that is adaptable to clinical practice and significantly correlates with OB volume loss in patients with idiopathic PD. Measuring both the volume and height of the OB by MRI may be a valuable method for the clinical investigation of PD.
许多神经病理学研究表明,嗅觉系统是帕金森病(PD)最早受影响的大脑区域之一。这些发现与病理生理学和病理学数据相关,表明 PD 患者嗅球(OB)体积减少。然而,迄今为止,MRI 并不是一种可靠的方法,无法在体内检测到 PD 中的这种体积损失。使用 3.0 特斯拉 MRI 稳态序列中的建设性干扰,评估了 PD 患者(n = 16)和健康对照组(n = 16)的 OB 体积。与健康对照组相比,PD 患者的 OB 体积明显减少(分别为 91.2 ± 15.72 和 131.4 ± 24.56 mm(3))。具体而言,左侧 OB 的高度降低似乎是一种可靠的参数,适用于临床实践,并与特发性 PD 患者的 OB 体积损失显著相关。通过 MRI 测量 OB 的体积和高度可能是 PD 临床研究的一种有价值的方法。